Cytosorbents Corp
CTSO- Exchange
- Nasdaq
- Industry
- Surgical & Medical Instruments & Apparatus
- SEC CIK
- 0001175151
In the last 90 days, Cytosorbents Corp insiders filed 4 open-market purchases and 0 sales; 50 institutions reported holding it in 13F filings for Q2 2026, worth $6.04M in total; no superinvestor holds it.
Q1 2023 vs. Q4 2022
How the institutions holding Cytosorbents Corp changed between Q4 2022 and Q1 2023.
All holders in Q1 2023All holders in Q4 2022
| Measure | Q4 2022 | Q1 2023 | Change |
|---|---|---|---|
| Holders | 53 | 59 | +6 |
| Shares | 14.7M | 15.2M | +557.3K (+3.8%) |
| Value | $22.7M | $51.3M | +$28.6M (+126.2%) |
New holders (8)
Institutions that held Cytosorbents Corp at the end of Q1 2023 but not at the end of Q4 2022.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Jane Street Group, LLC | 62,473 | $210.5K | 0.00% |
| NWF Advisory Services Inc. | 44,450 | $159.6K | 0.04% |
| Goldman Sachs Group Inc | 15,365 | $51.8K | 0.00% |
| Regal Investment Advisors LLC | 14,034 | $47.3K | 0.00% |
| Citadel Advisors LLC | 13,192 | $44.5K | 0.00% |
| Coastal Investment Advisors, Inc. | 12,000 | $40.4K | 0.01% |
| Squarepoint Ops LLC | 11,360 | $38.3K | 0.00% |
| Belvedere Trading LLC | 10,668 | $36.0K | 0.02% |
Sold out (2)
Institutions that held Cytosorbents Corp at the end of Q4 2022 and filed for Q1 2023 without it.
| Institution | Shares, Q4 2022 | Value, Q4 2022 |
|---|---|---|
| GW&K Investment Management, LLC | 30 | $0 |
| IFP Advisors, Inc | 1,687 | – |